ArticleDiscover oncology2024

Evaluating KLHDC8A as a biomarker for glioma: impact on survival and proliferation through the Wnt/β-catenin pathway.

Yu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.